药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Lurbinectedin
The serum concentration of Lurbinectedin can be increased when it is combined with Linagliptin.
Tetracosactide
Pemigatinib
The metabolism of Pemigatinib can be decreased when combined with Linagliptin.
Tetracosactide
Tucatinib
Tucatinib may decrease the excretion rate of Linagliptin which could result in a higher serum level.
Tetracosactide
Selumetinib
The serum concentration of Selumetinib can be increased when it is combined with Linagliptin.
Tetracosactide
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Linagliptin.
Tetracosactide
Thyroid, porcine
Thyroid, porcine may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Tiratricol
Tiratricol may decrease the hypoglycemic activities of Linagliptin.
Tetracosactide
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Linagliptin.
Tetracosactide
Lumateperone
The serum concentration of Lumateperone can be increased when it is combined with Linagliptin.
Tetracosactide
Levamlodipine
The serum concentration of Levamlodipine can be increased when it is combined with Linagliptin.
Tetracosactide
Cenobamate
The serum concentration of Linagliptin can be decreased when it is combined with Cenobamate.
Tetracosactide
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Linagliptin.
Tetracosactide
Zanubrutinib
The metabolism of Zanubrutinib can be decreased when combined with Linagliptin.
Tetracosactide
Prednisolone acetate
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Linagliptin.
Tetracosactide
Methylprednisolone aceponate
The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Linagliptin.
Tetracosactide
Loteprednol
The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Linagliptin.
Tetracosactide
Hydrocortisone valerate
The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Linagliptin.
Tetracosactide
Hydrocortisone probutate
The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Linagliptin.
Tetracosactide
Hydrocortisone cypionate
The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Linagliptin.
Tetracosactide
Hydrocortisone butyrate
The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Linagliptin.